Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | — | 0 | 0 | 0 | 12,000 | 238,000 |
| Cost of revenue | — | 0 | 0 | 0 | 1,000 | 30,000 |
| Gross profit | — | 0 | 0 | 0 | 11,000 | 208,000 |
| Research and development | 20M | 25M | 27M | 23M | 17M | 15M |
| Selling, general and administrative | 9M | 9M | 14M | 9M | 8M | 8M |
| Operating expenses | 34M | 1.16B | 91M | 475M | 47M | 45M |
| Operating income | −34M | −1.16B | −91M | −475M | −47M | −45M |
| Income tax | 0 | −1M | −2M | 397,000 | −5M | −2M |
| Net income | −10M | −411M | −28M | −119M | 818,000 | −4M |
| Earnings per share | −0.12 | −5.28 | −0.36 | −1.55 | 0.01 | −0.06 |
| Earnings per share, diluted | −0.12 | −5.28 | −0.36 | −1.55 | 0.01 | −0.06 |
| Weighted average shares | 85M | 78M | 78M | 77M | 74M | 72M |
| Weighted average shares, diluted | 85M | 78M | 78M | 77M | 74M | 72M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 133M | 199M | 229M | 284M | 300M | 329M | 386M | 405M |
| Receivables | — | — |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | −51M | — | — | −20M | — | — |
| Depreciation and amortisation | 3M | 16M | 22M | 22M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| — |
| — |
| — |
| 0 |
| 0 |
| 243,000 |
| Current assets | 311M | 344M | 370M | 409M | 498M | 513M | 564M | 583M |
| Property, plant and equipment | 41M | 33M | 16M | 97M | 100M | 151M | 131M | 108M |
| Goodwill | — | 0 | 0 | 0 | 0 | 360M | 360M | 360M |
| Total assets | 543M | 600M | 630M | 1.79B | 1.84B | 2.29B | 2.34B | 2.36B |
| Current liabilities | 13M | 47M | 22M | 42M | 21M | 18M | 27M | 15M |
| Total liabilities | 25M | 64M | 47M | 59M | 40M | 132M | 91M | 116M |
| Equity | 205M | 204M | 144M | 616M | 637M | 656M | 767M | 730M |
| 20M |
| 20M |
| Share-based compensation | 9M | — | — | 10M | — | — |
| Capital expenditure | 8M | — | — | 9M | — | — |
| Investing cash flow | −16M | — | — | −9M | — | — |
| Financing cash flow | −73,000 | — | — | −50,000 | — | — |